Current Atherosclerosis Reports

Papers
(The TQCC of Current Atherosclerosis Reports is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Revascularization Options for Left Main Disease: What Clinicians Need to Know121
Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?113
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes103
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management88
A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment68
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions66
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?65
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis64
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management63
The Effects of FABP4 on Cardiovascular Disease in the Aging Population63
Heart Transplant, Kawasaki Disease, and Bone Marrow Transplant: Are There Consequences?63
Anti-apoC-III Therapies and Implications for Treatment of Pancreatitis and Cardiovascular Disease56
The Role of the PI3K/Akt/mTOR Pathway in Atherosclerosis: Mechanisms, Therapeutic Potential, and Emerging Targeted Treatments55
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?54
Effects of Pioglitazone On Lipoprotein(a): A Meta-analysis54
Salutary Effects of Nutritional Ketosis for the Diseased Human Heart54
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators47
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond47
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice46
DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm45
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women44
Spontaneous Coronary Artery Dissection (SCAD): Unveiling the Enigma of the Unexpected Coronary Event43
The Emerging Specialty of Cardio-Rheumatology39
Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?37
Correction to: Beta‑blockers for Atherosclerosis Prevention: a Missed Opportunity?37
Recent Advances and Perspectives of Metabolomics-Based Investigations in Coronary Heart Disease37
Inflammation in the Peri-ACS Period: Ready for Prime Time?35
Myeloid Cells in Abdominal Aortic Aneurysm35
Percutaneous Coronary Interventions in Women35
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention34
The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review34
GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?32
The Role of Sleep in Cardiovascular Disease32
Programmable Genome-Editing Technologies as Single-Course Therapeutics for Atherosclerotic Cardiovascular Disease31
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women30
Lipoprotein(a): from Causality to Treatment29
ApoC-III as Therapeutic Target: Is it Primetime for Clinical Use?29
Low LDL-C: Is It all Good News?29
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease28
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?27
Importance of Nutrition Security to CVD Prevention Efforts in the USA26
The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger25
Childhood Hypertriglyceridemia: Is It Time for a New Approach?25
Update on Plant-Based Diets and Cardiometabolic Risk24
Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion24
Can Clinical Biomarkers Guide Optimal Therapeutic Selection in Type 2 Diabetes Mellitus? A Scoping Review24
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?24
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know24
Transgender Cardiovascular Health: Practical Management for the Clinician23
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment23
Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis22
Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis22
Correction to: High-Density Lipoproteins and Serum Amyloid A (SAA)21
Evidence Gaps in Assessments of the Healthiness of Online Supermarkets Highlight the Need for New Monitoring Tools: a Systematic Review20
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference20
Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?20
Factors Affecting Circulating Phytosterol Levels: Toward an Integrated Understanding of Atherogenicity and Atheroprotection by Dietary and Circulating Phytosterols20
Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction20
Dairy Foods: Is Its Cardiovascular Risk Profile Changing?20
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity20
Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease18
Exploring the Role of SPARC in Atherosclerosis: Mechanisms and Potential Implications18
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?18
SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor18
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference18
HIV and Cardiovascular Disease Burden in Young Adults (18–25 years): A Review of Current Evidence17
Is There a Role for Imaging Youth at Risk of Atherosclerosis?17
Gene Regulatory Networks in Coronary Artery Disease17
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know17
Transforming Population Health Screening for Atherosclerotic Cardiovascular Disease with AI-Enhanced ECG Analytics: Opportunities and Challenges17
Clinical Management of Dyslipidemia in Infants and Toddlers17
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precision Medicine17
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?17
Cardiovascular Disease in the Middle East and North Africa, 1990–2021: Burden, Trends, and Risk Factors17
Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men16
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis16
Natural Sirtuin1 Activators and Atherosclerosis: an Overview16
Expanding Clinical Indications for Cardiac CT: A Review of Its Current Utility in American and European Guidelines16
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults16
Cardiovascular Health and Disease in the Pakistani American Population16
What Causes Premature Coronary Artery Disease?15
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population15
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference15
Targeting the Gut Microbiome to Treat Cardiometabolic Disease15
Bempedoic Acid: for Whom and When15
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician15
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field15
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review15
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms14
Serial Coronary CTA for Monitoring Response to Lipid-Lowering Therapy: A Narrative Review14
The Role of Lysyl Oxidase in the Pathological Stage of Atherosclerosis: Structural Stabilizer or Disease Driver?14
Dietary Management of Atherogenic Dyslipidemia14
Non-obstructive Plaque and Treatment of INOCA: More to Be Learned14
Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?14
Utility of FFRCT in Patients with Chest Pain14
Correlation Between Oral Bacteria and Atherosclerotic Thrombotic Disease: Advances in Animal Model Studies14
Combined Dyslipidemia in Children and Adolescents: a Proposed New Management Approach14
0.14038896560669